Chad Urie: As Life Sciences Gain Momentum, Research Facilities are Increasingly Vital

NEW YORK, NY, August 09, 2012

Companies in many different industries continue to face significant economic hardships; even as the nation's economy takes tentative steps toward recovery, many verticals are still struggling simply to stay afloat. There are noteworthy exceptions to that rule, however, as several companies that manufacture life science research tools are reporting significant profits and surprising growth. This finding shows that, even amidst economic tumult, the life sciences are continuing to prosper. This positive trend has won the attention of industry experts like Chad Urie, who responds to the latest economic figures with a new statement to the press.

Urie's press statement follows on the heels of a promising report form Wall Street, which finds three research tool manufacturers attaining better-than-expected earnings for the second quarter of 2012. These three companies, which have improved their earnings forecasts for 2012 on the back of a strong second quarter, include Thermo Fisher Scientific, up 8.76 percent for the second quarter; Qiagen, up 5.9 percent; and Illumina, up 0.43 percent. All three companies far exceeded economic predictions, based largely on an increased demand for diagnostic products from various biopharmaceutical companies across the world.

This good news could not help but attract the attention of Chad Urie. A San Diego-based real estate professional, Urie's specialty is in delivering commercial real estate and facilities management services to life science companies. Urie's passion is for helping life science companies grow through strategic real estate acquisitions--and in his new press statement, he says these positive economic indicators serve to show how vital the life sciences really are.

Urie says that life science companies are growing not just because of the important role they play in medical development, but also because of financial savvy. "With the abundance of M&A activity on the rise, many life science companies are considering how they structure their facility obligations," Urie explains. "The proper structuring of facility obligations can have a significant impact on the overall acquisition pricing. Today, many companies are growing more conservatively and structuring transactions that provide flexibility."

Chad Urie currently serves as Senior Vice President for the firm of Jones Lang LaSalle. This firm provides commercial real estate services aimed at life science companies; among these services are real estate consultation, facilities management, laboratory upkeep, and more.

The financial report itself notes that life science companies look to biopharmaceutical firms as their primary areas of focus. This marks a shift from the industry's traditional focus on colleges and universities, which are increasingly conservative in their budgets for research tools. Increased demand for these research tools in international markets is also a key factor in this economic growth.

ABOUT:

Chad Urie is a San Diego-based real estate professional with a wealth of experience in the fields of landlord representation, corporate tenant representation, investment services, market analysis, and portfolio review. Currently, Mr. Urie serves as a Senior Vice President for the firm Jones Lang LaSalle, where he specializes in commercial real estate services for life science companies.

Website: http://www.linkedin.com/in/chadurie